| [1] |
Li Y, Ning Y, Shen B, et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the global burden of disease study 2019 [J]. Clin Kidney J, 2022, 16(2): 312-321.
|
| [2] |
Verduzco HA, Shirazian S. CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management [J]. Kidney Int Rep, 2020, 5(9): 1387-1402.
|
| [3] |
Molina P, Ojeda R, Blanco A, et al. Etiopathogenesis of chronic kidney disease-associated pruritus: putting the pieces of the puzzle together [J]. Nefrologia (Engl Ed), 2023, 43(1): 48-62.
|
| [4] |
Cevikbas F, Lerner EA. Physiology and pathophysiology of itch [J]. Physiol Rev, 2020, 100(3): 945-982.
|
| [5] |
Hu X, Sang Y, Yang M, et al. Prevalence of chronic kidney disease-associated pruritus among adult dialysis patients: a meta-analysis of cross-sectional studies [J]. Medicine (Baltimore), 2018, 97(21): e10633.
|
| [6] |
Esteve-Simó V, Perez-Morales R, Buades-Fuster JM, et al. Chronic kidney disease-associated pruritus and quality of life: learning from our patients [J]. J Clin Med, 2023, 12(13): 4505.
|
| [7] |
Agarwal R, Burton J, Gallieni M, et al. Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus [J]. Clin Kidney J, 2022, 16(1): 30-40.
|
| [8] |
Oweis AO, Al-Qarqaz F, Bodoor K, et al. Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus [J]. Cytokine, 2021, 138: 155369.
|
| [9] |
Zhao JH, Zhu QS, Li YW, et al. Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: a cross-sectional study [J]. PLoS One, 2021, 16(1): e0245370.
|
| [10] |
Ko MJ, Peng YS, Wu HY. Uremic pruritus: pathophysiology, clinical presentation, and treatments [J]. Kidney Res Clin Pract, 2023, 42(1): 39-52.
|
| [11] |
Melo H, Basso L, Iftinca M, et al. Itch induced by peripheral mu opioid receptors is dependent on TRPV1-expressing neurons and alleviated by channel activation [J]. Sci Rep, 2018, 8(1): 15551.
|
| [12] |
Wieczorek A, Krajewski P, Kozioł-Gałczyńska M, et al. Opioid receptors expression in the skin of haemodialysis patients suffering from uraemic pruritus [J]. J Eur Acad Dermatol Venereol, 2020, 34(10): 2368-2372.
|
| [13] |
Fan M, Fan X, Lai Y, et al. Protease-activated receptor 2 in inflammatory skin disease: current evidence and future perspectives [J]. Front Immunol, 2024, 15: 1448952.
|
| [14] |
Xie B, Li XY. Inflammatory mediators causing cutaneous chronic itch in some diseases via transient receptor potential channel subfamily V member 1 and subfamily A member 1 [J]. J Dermatol, 2019, 46(3): 177-185.
|
| [15] |
Kim SJ, Zhang X, Cho SB, et al. Uremic solutes of indoxyl sulfate and p-cresol enhance protease-activated receptor-2 expression in vitro and in vivo in keratinocytes [J]. Hum Exp Toxicol, 2021, 40(1): 113-123.
|
| [16] |
Kim HS, Yosipovitch G. The skin microbiota and itch: is there a link? [J]. J Clin Med, 2020, 9(4): 1190.
|
| [17] |
Xie Q, Hu N, Chen Y. Chronic kidney disease-associated pruritus significantly impacts on quality of life of patients on haemodialysis and associates with increased levels of serum calcium and phosphorus [J]. Postgrad Med J, 2022, 98(1161): e16.
|
| [18] |
Shirazian S, Kline M, Sakhiya V, et al. Longitudinal predictors of uremic pruritus [J]. J Ren Nutr, 2013, 23(6): 428-431.
|
| [19] |
Liu F, Xu X, Chao L, et al. Alteration of the gut microbiome in chronic kidney disease patients and its association with serum free immunoglobulin light chains [J]. Front Immunol, 2021, 12: 609700.
|
| [20] |
Tang Z, Yu S, Pan Y. The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies [J]. J Transl Med, 2023, 21(1): 689.
|
| [21] |
Wu CC, Tian YC, Lu CL, et al. AST-120 improved uremic pruritus by lowering indoxyl sulfate and inflammatory cytokines in hemodialysis patients [J]. Aging (Albany NY), 2024, 16(5): 4236-4249.
|
| [22] |
Akl EM, El-Eraki JM, Elfallah AA, et al. Does indoxyl sulfate have a role in uremic pruritus? A laboratory and interventional study [J]. J Cutan Med Surg, 2024, 28(1): 44-50.
|
| [23] |
Lee JG, Seo H, Son SS, et al. Loss of cutibacterium is responsible for chronic kidney disease-associated pruritus in patients on dialysis [J]. Kidney Res Clin Pract, 2025, 44(1): 176-188.
|
| [24] |
Tian Y, Gu C, Yan F, et al. Alteration of skin microbiome in CKD patients is associated with pruritus and renal function [J]. Front Cell Infect Microbiol, 2022, 12: 923581.
|
| [25] |
Chang PC, Liao IC. Hydration, barrier of skin and uremic pruritus in patients undergoing hemodialysis: a pilot investigation [J]. Nephrol Ther, 2022, 18(6): 498-505.
|
| [26] |
Ibrahim AM, Chauhan L, Bhardwaj A, et al. Brain-derived neurotropic factor in neurodegenerative disorders [J]. Biomedicines, 2022, 10(5): 1143.
|
| [27] |
Sorour NE, Elesawy FM, Tabl HA, et al. Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients [J]. Clin Cosmet Investig Dermatol, 2019, 12: 109-114.
|
| [28] |
Zhao D, Wang Y, Wang Y, et al. Randomized control study on hemoperfusion combined with hemodialysis versus standard hemodialysis: effects on middle-molecular-weight toxins and uremic pruritus [J]. Blood Purif, 2022, 51(10): 812-822.
|
| [29] |
Puspitasari M, Hidayat ARP, Wijaya W, et al. Effectiveness of combined hemodialysis-hemadsorption therapy in improving uremic toxin clearance, inflammatory markers, and symptoms in maintenance hemodialysis patients [J]. Blood Purif, 2024, 53(9): 732-742.
|
| [30] |
Palleschi S, Ghezzi PM, Palladino G, et al. Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra [J]. BMC Nephrol, 2016, 17(1): 120.
|
| [31] |
潘明明,谢筱彤,高民,等. 血液滤过吸附再回输在维持性血液透析患者中的应用疗效研究[J]. 中国血液净化,2021, 20(10): 674-675, 692
|
| [32] |
Zha F, Li W, Shi C, et al. Early clinical observation of supra-hemodiafiltration with endogenous reinfusion in the treatment of uremic pruritus [J]. Artif Organs, 2023, 47(9): 1503-1513.
|
| [33] |
Szepietowski JC, Kemeny L, Mettang T, et al. Long-term efficacy and tolerability of an emollient containing glycerol and paraffin for moderate-to-severe uremic xerosis: a randomized phase 3 study [J]. Dermatol Ther (Heidelb), 2024, 14(11): 3033-3046.
|
| [34] |
Yosipovitch G, Awad A, Spencer RH, et al. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus [J]. J Am Acad Dermatol, 2023, 89(2): 261-268.
|
| [35] |
Zhang P, Xiang S, Liu B, et al. Randomized controlled trial of nalfurafine for refractory pruritus in hemodialysis patients [J]. Ren Fail, 2023, 45(1): 2175590.
|
| [36] |
Najafabadi MM, Faghihi G, Emami A, et al. Zinc sulfate for relief of pruritus in patients on maintenance hemodialysis [J]. Ther Apher Dial, 2012, 16(2): 142-145.
|
| [37] |
Feily A, Dormanesh B, Ghorbani AR, et al. Efficacy of topical cromolyn sodium 4% on pruritus in uremic nephrogenic patients: a randomized double-blind study in 60 patients [J]. Int J Clin Pharmacol Ther, 2012, 50(7): 510-513.
|
| [38] |
Zhao X, Sun H, Li W. Efficacy and safety of different systemic drugs in the treatment of uremic pruritus among hemodialysis patients: a network meta-analysis based on randomized clinical trials [J]. Front Med (Lausanne), 2024, 11: 1334944.
|
| [39] |
Nofal E, Farag F, Nofal A, et al. Gabapentin: a promising therapy for uremic pruritus in hemodialysis patients: a randomized-controlled trial and review of literature [J]. J Dermatolog Treat, 2016, 27(6): 515-519.
|
| [40] |
Khan TM, Wu DB, Goh BH, et al. An observational longitudinal study investigating the effectiveness of 75 mg pregabalin post-hemodialysis among uremic pruritus patients [J]. Sci Rep, 2016, 6: 36555.
|
| [41] |
Gholyaf M, Sheikh V, Yasrebifar F, et al. Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study [J]. Int Urol Nephrol, 2020, 52(6): 1155-1165.
|
| [42] |
Elsayed MM, Elgohary IE, Abdelhamid HHS, et al. The effectiveness of sertraline in alleviating uremic pruritus in hemodialysis patients: a randomized clinical trial [J]. BMC Nephrol, 2023, 24(1): 155.
|
| [43] |
Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications [J]. Allergy Asthma Proc, 2019, 40(2): 84-92.
|
| [44] |
Baharvand P, Abbasi MR, Ziaee Ardestani S, et al. Evaluation of antipruritic effect of melatonin on hemodialysis patients with uremic pruritus, a double-blind, randomized, crossover trial [J]. Iran J Kidney Dis, 2021, 1(1): 38-47.
|
| [45] |
Song YH, Wang SY, Lang JH, et al. Therapeutic effect of intravenous sodium thiosulfate for uremic pruritus in hemodialysis patients [J]. Ren Fail, 2020, 42(1): 987-993.
|
| [46] |
Lu PH, Lai CC, Chiu LY, et al. Comparative efficacy of Chinese herbal medicines for dialysis patients with uremic pruritus: a systematic review and network meta-analysis [J]. Front Pharmacol, 2023, 14: 1064926.
|
| [47] |
Tang Y, Cheng S, Wang J, et al. Acupuncture for the treatment of itch: peripheral and central mechanisms [J]. Front Neurosci, 2022, 15: 786892.
|
| [48] |
Lu PH, Chuo HE, Chiu LY, et al. Comparative efficacy of acupuncture point stimulation treatments for dialysis patients with uremic pruritus: a systematic review and network meta-analysis [J]. Front Neurol, 2024, 15: 1342788.
|
| [49] |
Hari Kumar KV, Prajapati J, Pavan G, et al. Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis [J]. Hemodial Int, 2010, 14(1): 73-77.
|
| [50] |
白璐,朱才勇. 获得性反应性穿通性胶原病的研究进展[J].皮肤病与性病,2024, 46(5): 302-305.
|
| [51] |
郑林,莫友,李倩,等. 维持血液透析并发获得性反应性穿通性胶原病二例并文献复习[J].中国麻风皮肤病杂志,2024, 40 (12): 866-869.
|